ES8600327A1 - Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a - Google Patents

Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a

Info

Publication number
ES8600327A1
ES8600327A1 ES527249A ES527249A ES8600327A1 ES 8600327 A1 ES8600327 A1 ES 8600327A1 ES 527249 A ES527249 A ES 527249A ES 527249 A ES527249 A ES 527249A ES 8600327 A1 ES8600327 A1 ES 8600327A1
Authority
ES
Spain
Prior art keywords
epi
aza
antibacterial
azahomoerythromycin
epimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527249A
Other languages
English (en)
Spanish (es)
Other versions
ES527249A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES527249A0 publication Critical patent/ES527249A0/es
Publication of ES8600327A1 publication Critical patent/ES8600327A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Cosmetics (AREA)
ES527249A 1982-11-15 1983-11-14 Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a Expired ES8600327A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15

Publications (2)

Publication Number Publication Date
ES527249A0 ES527249A0 (es) 1985-10-01
ES8600327A1 true ES8600327A1 (es) 1985-10-01

Family

ID=23755068

Family Applications (2)

Application Number Title Priority Date Filing Date
ES527249A Expired ES8600327A1 (es) 1982-11-15 1983-11-14 Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a
ES543638A Expired ES8604257A1 (es) 1982-11-15 1985-05-29 Un procedimiento para la preparacion de 4-epi-9-desoxo-9a- metil-9a-aza-9a-homoeritromicina a

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES543638A Expired ES8604257A1 (es) 1982-11-15 1985-05-29 Un procedimiento para la preparacion de 4-epi-9-desoxo-9a- metil-9a-aza-9a-homoeritromicina a

Country Status (26)

Country Link
EP (1) EP0109253B1 (2)
JP (1) JPS59104398A (2)
KR (1) KR850000968B1 (2)
AT (1) ATE30237T1 (2)
AU (1) AU544790B2 (2)
CA (1) CA1239639A (2)
CS (1) CS241069B2 (2)
DD (1) DD216017A5 (2)
DE (1) DE3374065D1 (2)
DK (1) DK159322C (2)
EG (1) EG16641A (2)
ES (2) ES8600327A1 (2)
FI (1) FI72980C (2)
GR (1) GR79425B (2)
GT (1) GT198304062A (2)
HU (1) HU193886B (2)
IE (1) IE56234B1 (2)
IL (1) IL70228A (2)
NO (1) NO160262C (2)
NZ (1) NZ206259A (2)
PH (2) PH19293A (2)
PL (2) PL143281B1 (2)
PT (1) PT77645B (2)
SU (1) SU1272996A3 (2)
YU (2) YU43198B (2)
ZA (1) ZA838460B (2)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
DE3475073D1 (en) * 1983-09-06 1988-12-15 Pfizer Azahomoerythromycin b derivatives and intermediates thereof
RO107257B1 (ro) * 1987-07-09 1993-10-30 Pfizer Procedeu de obtinere a unui dihidrat de azitromicina, cristalin
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
SI8911498B (sl) * 1989-07-26 1998-10-31 Pliva Postopek za pripravo derivatov tilozina
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065674A1 (en) * 1991-04-10 1992-10-11 Robert R. Wilkening 8a-aza-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
CA2068951A1 (en) * 1991-05-20 1992-11-21 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
EP0758244B2 (en) 1994-05-06 2008-02-13 Pfizer Inc. Controlled-release dosage forms of azithromycin
AU704596B2 (en) * 1995-06-29 1999-04-29 Texas Biotechnology Corporation Di- and trivalent small molecule selectin inhibitors
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
PT1206476E (pt) * 1999-08-24 2006-05-31 Abbott Lab 9a-azalidos com actividade antibacteriana
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
CA2396426A1 (en) * 2000-01-04 2001-07-12 Teva Pharmaceutical Industries Ltd. Preparation method of azithromycin dihydrate
WO2002015842A2 (en) 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
CA2549225A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
ATE399536T1 (de) 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
SU1272996A3 (ru) 1986-11-23
GT198304062A (es) 1985-05-04
FI834163A0 (fi) 1983-11-14
IL70228A0 (en) 1984-02-29
NO160262C (no) 1989-03-29
JPS59104398A (ja) 1984-06-16
EG16641A (en) 1990-08-30
NO834146L (no) 1984-05-16
CS845583A2 (en) 1985-07-16
ZA838460B (en) 1985-06-26
AU544790B2 (en) 1985-06-13
ES527249A0 (es) 1985-10-01
YU197285A (en) 1986-08-31
FI72980B (fi) 1987-04-30
PL142601B1 (en) 1987-11-30
GR79425B (2) 1984-10-22
KR840006673A (ko) 1984-12-01
DK518683D0 (da) 1983-11-14
FI834163L (fi) 1984-05-16
PT77645A (en) 1983-12-01
EP0109253A3 (en) 1984-09-12
AU2130983A (en) 1984-05-24
PH21560A (en) 1987-12-11
DK159322B (da) 1990-10-01
IE56234B1 (en) 1991-05-22
EP0109253B1 (en) 1987-10-14
PL143281B1 (en) 1988-01-30
DE3374065D1 (en) 1987-11-19
EP0109253A2 (en) 1984-05-23
YU43198B (en) 1989-04-30
IL70228A (en) 1987-03-31
PL250350A1 (en) 1985-04-24
CS241069B2 (en) 1986-03-13
CA1239639A (en) 1988-07-26
DK159322C (da) 1991-02-25
KR850000968B1 (ko) 1985-07-02
YU224383A (en) 1986-04-30
DK518683A (da) 1984-05-16
ATE30237T1 (de) 1987-10-15
PL244557A1 (en) 1985-03-26
JPH0140038B2 (2) 1989-08-24
FI72980C (fi) 1987-08-10
DD216017A5 (de) 1984-11-28
HUT35273A (en) 1985-06-28
ES543638A0 (es) 1986-01-16
NZ206259A (en) 1986-08-08
YU43425B (en) 1989-06-30
PT77645B (en) 1986-05-12
NO160262B (no) 1988-12-19
HU193886B (en) 1987-12-28
PH19293A (en) 1986-03-04
IE832652L (en) 1984-05-15
ES8604257A1 (es) 1986-01-16

Similar Documents

Publication Publication Date Title
ES8600327A1 (es) Un procedimiento para la preparacion de 4"-epi-9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a
ES2075887T3 (es) Procedimiento de preparacion de acido ascorbico.
ES8406413A1 (es) Un procedimiento para preparar derivados de fenilciclobutano.(como divisional de la patente numero 511.152)
ES2051700T3 (es) Un proceso para la preparacion de un compuesto beta-lactama.
ES8702880A1 (es) Un procedimiento para la produccion de compuestos de fenetanolamina.
UY25330A1 (es) Nuevos macrólidos
DK118286D0 (da) Terapeutisk aktive nucleosider, deres anvendelse og farmaceutiske kompositioner indeholdende forbindelserne
ES8404987A1 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno y de indano.
ES8607335A1 (es) Un procedimiento para la preparacion de un antibiotico de macrolida
ES8305770A1 (es) Un procedimiento para la preparacion de bis-esteres de metanodiol.
ES2052732T3 (es) 2',3'-didesoxi-3'-fluorotimidina y compuestos afines para el tratamiento de infecciones por adenovirus.
TR200101474T2 (tr) Yeni ara maddeler, bunlardan makrolid antibiyotik aktif madde hazırlanması.
ES8801664A1 (es) Un procedimiento para la preparacion de derivados de acidos griseolicos.
ES8301878A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
KR890009964A (ko) 항생물질 a/16686의 신규 수소첨가 유도체
ES8801173A1 (es) Procedimiento de producir agentes terapeuticos y profilacticos para ulceras pepticas
IE801677L (en) An antimycotic vaginal tablet
FR2567520B1 (fr) Nouvelles phenyl-naphthyridines, leur procede de preparation, medicaments les contenant, notamment anti-ulceres
ES8603506A1 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina b o una sal de la misma
ES8305349A1 (es) "procedimiento para la fabricacion de derivados de las (tienil-2) y (tienil-3)-2 etilaminas".
ES8407011A1 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
KR880013964A (ko) 테이코플라닌 유도체
ES8308562A1 (es) Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas
ES8801625A1 (es) Procedimiento para preparar disulfuros heterociclicos
IT1255982B (it) Composti di inclusione di nimesulide con ciclodestrina e procedimento per la preparazione di tali composti

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040626